Effects of a high CBD cannabis extract on pain in Complex Regional Pain Syndrome
Official title: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
Run by University of California, San Diego · NCT06393101 · Data updated 2026-11-12
This study is testing whether a high CBD cannabis extract can help people with Complex Regional Pain Syndrome find relief from their pain.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years to 75 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 2 sites (La Jolla, California and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | June 1, 2029 |
| Study ends | June 1, 2029 |
| Registry record updated | June 7, 2024 |
| Trial ID | NCT06393101 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21-75 with a confirmed diagnosis of CRPS for at least three months who have been cannabis-free for 30 days prior to participation.
✕Probably not a fit
Patients with active pulmonary disease or those who have had adverse reactions to cannabis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to explore the effects and mechanisms of a high CBD cannabis extract (BRC-002) on pain relief in individuals suffering from Complex Regional Pain Syndrome (CRPS). It employs multiple psychophysical assessments alongside psychological and inflammatory marker testing to evaluate how cannabinoids may lead to sustained improvements in pain and related symptoms. The study includes a pre-treatment screening phase, a six-week treatment period, and a two-week follow-up to monitor outcomes. Participants will be closely monitored to ensure compliance with cannabis abstinence during the study.
Why it matters
Potential benefit: If successful, this study could provide a novel therapeutic option for managing pain in patients with Complex Regional Pain Syndrome.
How similar studies have gone: While the use of cannabinoids for pain management is being explored, this specific approach in CRPS is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Are between 21-75 years old 3. Ability to communicate in English 4. Volunteers with no previous medical history (e.g., cardiac or pulmonary disease) 5. Are not currently using any type of cannabis, including hemp or CBD 6. Currently 30 days cannabis free 7. Participants with ongoing CRPS \[Type 1 or Type 2)\] for at least 3 months prior to participation (medical record confirmed) 8. Agrees not to use cannabis, including hemp or CBD, outside of the study during participation in the study 9. Agrees not to use opioids or barbiturates during participation in the study Exclusion Criteria: 1. Fail cannabis screening 2. Active pulmonary disease 3. Allergy or past adverse effects or negative past experiences from cannabis 4. Positive urine drug test for THC, barbiturates, opioids, oxycodone, or methadone prior to study session 1 or session 2 5. Any significant illness, including cardiovascular disease, diabetes, renal and liver disease 6. Any current or history of an immunocompromising disease or condition (such as lupus, psoriasis, multiple sclerosis, etc.) 7. Any current or history of neurologic conditions, including Parkinson disease, dementia, cognitive impairment, history of seizure disorder, and history of traumatic brain injury/head injury 8. Participant meets DSM-V criteria for current major psychiatric illness, such as bipolar disorder, major depression, psychosis, substance use disorder, or schizophrenia 9. Any current or history of suicidal ideation or attempt 10. Patients with clinically significant laboratory abnormalities
Where it's running
-
Altman Clinical and Translational Research Institute
La Jolla, California, United States Recruiting -
University of California, San Diego
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Fadel Zeidan, PhD — UC San Diego
- Study coordinator: Fadel Zeidan, PhD
- Email: fzeidan@health.ucsd.edu
- Phone: 858-246-8341
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how a wrist fracture heals and why some people develop long-lasting pain
This study tests whether genetic markers, blood signals, heart-rate patterns, and brain body maps can predict which patients will have persistent pain after a distal radius fracture.
-
Hyperbaric oxygen therapy for severe CRPS
This trial tests whether adding hyperbaric oxygen therapy helps people with severe complex regional pain syndrome compared with a delayed-start approach.
-
Effects of whirlpool and contrast baths on pain in patients with complex regional pain syndrome after wrist fractures
This study is testing whether whirlpool and contrast baths can help reduce pain and improve function in adults with complex regional pain syndrome after a wrist fracture.
-
Using low-dose naltrexone to relieve pain in complex regional pain syndrome
This study is testing if low-dose naltrexone can help people with complex regional pain syndrome feel less pain.
-
Non-invasive brain stimulation to see if it changes pain avoidance in CRPS
This study tests whether a gentle brain stimulation method called tACS can change how people with complex regional pain syndrome avoid activities that might worsen their pain.
-
tDCS for CRPS: see if a non‑invasive brain stimulation helps reduce pain
This trial tests whether transcranial direct current stimulation can lessen pain and improve mood and function for people with complex regional pain syndrome.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.